NIH updates clinical trial definition to exclude basic experimental studies involving humans from clinical trial requirements starting May 2026.

In a long-debated move, the NIH will no longer characterize basic experimental studies involving humans as clinical trials.

Susan Vadaparampil, PhD, MPH, of Moffitt Cancer Center, concludes her conversation with The American Journal of Managed Care® at last month’s Institute for Value-Based Medicine ® event in Tampa, ...

Advocate Health is scaling clinical trial network across six states to integrate research into routine care at ...

The AISight® Clinical Trials Platform provides a robust, GCP/GCLP-compliant environment that bridges the gap between traditional pathology and computational precision. By launching these tools on ...

Nearly 4% of 11,008 clinical trials lost funding due to Trump administration NIH grant terminations, and some 74,000 patients were affected. Trials for which grants were terminated disproportionately ...

In this free webinar, learn about the importance of returning patient data to rare disease clinical trial participants. Attendees will gain insight into the regulatory expectations and ethical ...

Clinical research organization Veristat has a new leader as the Southborough-based firm promoted Kim McLean Boericke to the role of CEO.

Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary ...

SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it ...

AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate them.

Over recent decades, advances in cancer treatment have yielded substantial improvements in patient outcomes, driving up survival, and even rendering some cancers curable. These advances have been ...